MedTrace Logo

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

NCT05937321 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2026-04-13

No results posted yet for this study

Summary

The purpose of this study is to test the Share plus intervention aimed at improving the use of data sharing between people with diabetes and their care partners in order to maximize the benefits of continuous glucose monitoring.

Hypothesis: Compared to the control group, persons with diabetes enrolled in the Share plus intervention group will experience clinically significant improvements in time-in-range (TIR) (\>5%) at 12- and 24-weeks into the study, and improvement on diabetes distress. Care partners enrolled in the Share plus intervention group will experience lower diabetes distress at 12- and 24-weeks into the study.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

BEHAVIORAL

Share plus intervention

Participants will receive the Share plus intervention: * Set up Follow app * Start Share plus intervention * Communication and problem-solving strategies * Detailed action plan including glucose targets * Review communication and problems * New communication content * Revise action plan as needed for communication and problem-solving hypo- and hyperglycemia, * Dyadic glucose pattern management training using Clarity, set automatic Clarity downloads * Dyad set goals for regular times to discuss glucose trends and problem-solving * Dyadic review of glucose targets after an in-depth analysis of CGM data and dyadic treatment strategies to improve glucose TIR

BEHAVIORAL

Control group

Diabetes self-management education materials

Sponsors & Collaborators

Principal Investigators

  • Nancy A Allen, PhD · University of Utah College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-02
Primary Completion
2026-04-20
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05937321 on ClinicalTrials.gov